Introduction
TDP2 (Tyrosyl-DNA Phosphodiesterase 2), also known as TTRAP (TNF Receptor-Associated Protein) or EAP-II, is a critical DNA repair enzyme specialized in resolving topoisomerase II (TOP2)-induced DNA damage. Located on chromosome 6p22.3, this enzyme plays an essential role in maintaining genomic stability in post-mitotic neurons, which are particularly vulnerable to accumulated DNA damage due to their inability to divide and replace themselves.
| Tyrosyl-DNA Phosphodiesterase 2 | |
|---|---|
| Gene Symbol | TDP2 |
| Full Name | tyrosyl-DNA phosphodiesterase 2 |
| Chromosome | 6p22.3 |
| NCBI Gene ID | [51567](https://www.ncbi.nlm.nih.gov/gene/51567) |
| OMIM | 614675 |
| Ensembl ID | ENSG00000111802 |
| UniProt ID | [Q9H2P2](https://www.uniprot.org/uniprot/Q9H2P2) |
| Protein Length | 362 amino acids |
| Molecular Weight | 40.5 kDa |
| Associated Diseases | Amyotrophic Lateral Sclerosis, Parkinson's Disease, Ataxia, Alzheimer's Disease |
Gene and Protein Structure
Gene Organization
The TDP2 gene spans approximately 12.5 kb and consists of 9 exons. The gene encodes a 362-amino acid protein with a molecular weight of approximately 40.5 kDa. The promoter region contains several transcription factor binding sites, including p53-responsive elements, indicating its regulation in response to DNA damage 1TDP2 and DNA repair in neurons (2020)Open reference.
Protein Domains
The TDP2 protein contains several key structural features:
-
N-terminal Domain (1-150 aa): Contains the catalytic core with the active site signature motif H^85WD^87 that coordinates metal ion-dependent phosphodiester hydrolysis
-
Central Region (150-280 aa): Contains the DNA binding domain essential for substrate recognition
-
C-terminal Domain (280-362 aa): Involved in protein-protein interactions with various cellular partners including transcription factors and DNA repair proteins
The three-dimensional structure reveals a α/β-fold with a central β-sheet surrounded by α-helices, characteristic of the metallo-hydrolase family 2TDP2 function and neurological disease (2020)Open reference.
Biochemical Function
Catalytic Activity
TDP2 is a Mg²⁺-dependent phosphodiesterase that specifically catalyzes the removal of covalent TOP2-DNA adducts ( TOP2 cleavage complexes, or TOP2cc). The reaction mechanism involves:
-
Binding: TDP2 recognizes and binds to the TOP2-DNA covalent complex
-
Hydrolysis: The catalytic site performs nucleophilic attack on the phosphodiester bond, releasing TOP2 from the DNA
-
Restoration: The DNA ends are resealed, restoring genomic integrity
This enzymatic activity is distinct from TDP1 (Tyrosyl-DNA Phosphodiesterase 1), which resolves TOP1-DNA adducts. Together, these two enzymes provide comprehensive protection against topoisomerase-induced DNA damage 3Tyrosyl-DNA phosphodiesterases in neurodegeneration (2019)Open reference.
Substrate Specificity
TDP2 demonstrates high specificity for:
-
TOP2 cleavage complexes (the primary substrate)
-
Covalent DNA-protein adducts generated by etoposide, doxorubicin, and other TOP2 poisons
-
Processing of TOP2 during normal DNA metabolism
Role in DNA Repair Pathways
Topoisomerase II-Mediated DNA Damage
Topoisomerase II is essential for resolving DNA supercoils during transcription, replication, and chromosome segregation. The enzyme creates double-strand breaks (DSBs) as an intermediate in its catalytic cycle, temporarily passing one DNA duplex through another. Under normal conditions, these DSBs are rapidly resealed. However, various conditions can trap TOP2cc:
-
Chemical inhibitors: Etoposide, doxorubicin, and anthracycline chemotherapeutics stabilize the cleavage complex
-
Endogenous stress: Reactive oxygen species (ROS) can oxidize TOP2, stabilizing its covalent linkage to DNA
-
Aging: Cumulative oxidative damage and decreased repair capacity lead to increased TOP2cc accumulation
The TDP2 Repair Pathway
The resolution of TOP2cc proceeds through a dedicated repair pathway:
graph TD
A["TOP2 Cleavage Complex"] --> B["TDP2 Binding"]
B --> C["Phosphodiester Hydrolysis"]
C --> D["TOP2 Release"]
D --> E["DNA Strand Break"]
E --> F["Ligase III/XRCC1 Repair"]
F --> G["Restored DNA"]-
TDP2 recognizes the TOP2cc through its DNA-binding domain
-
Catalytic hydrolysis releases TOP2, leaving a DSB with a 5’-phosphate and 3’-OH
-
The DSB is processed by the canonical non-homologous end joining (NHEJ) pathway
-
DNA ligase III in complex with XRCC1 completes the repair
Alternative Pathways
When TDP2 is deficient or overwhelmed:
-
Homologous recombination (HR) can be engaged, particularly in S/G2 phases
-
Base excision repair (BER) processes the resulting DNA ends
-
Error-prone microhomology-mediated end joining (MMEJ) may be utilized, leading to mutations
Expression Pattern
Tissue Distribution
TDP2 is ubiquitously expressed with highest levels in:
-
Brain: Particularly in neurons of the cortex, hippocampus, and substantia nigra
-
Testis: High proliferative activity requires robust DNA repair
-
Liver and Kidney: High metabolic activity and detoxification
-
Spinal Cord: Motor neurons show high expression
Cellular Localization
Within neurons, TDP2 localizes to:
-
Nucleus: Primary location for DNA repair functions
-
Nucleolus: Associated with ribosomal DNA transcription
-
Cytoplasm: Lower abundance, function unclear
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
Multiple lines of evidence implicate TDP2 dysfunction in ALS:
-
Genetic Associations: Polymorphisms in the TDP2 gene have been associated with increased ALS susceptibility in genome-wide association studies 4TDP2 polymorphisms and susceptibility to neurodegenerative diseases (2023)Open reference
-
DNA Damage Accumulation: ALS motor neurons show elevated levels of TOP2cc and persistent DNA damage markers
-
Oxidative Stress: Motor neurons are particularly vulnerable to ROS, which stabilizes TOP2cc
-
Impaired Repair: Post-mortem ALS tissue shows reduced TDP2 activity compared to age-matched controls
The mechanism involves failure to resolve TOP2-induced DSBs, leading to genomic instability, activation of DNA damage response pathways, and ultimately neuronal apoptosis 5Topoisomerase inhibitors for neurodegeneration (2021)Open reference.
Parkinson’s Disease (PD)
TDP2’s role in PD is emerging through several mechanisms:
-
Dopaminergic Neuron Vulnerability: The substantia nigra pars compacta (SNc) dopaminergic neurons have particularly high metabolic demands and oxidative stress, making them reliant on robust DNA repair
-
Mitochondrial Dysfunction: PD-associated mitochondrial dysfunction leads to increased ROS production, promoting TOP2cc formation
-
Age-Related Decline: TDP2 activity decreases with age, potentially contributing to late-onset PD
-
Interaction with PD Proteins: TDP2 may interact with α-synuclein and parkin, though this requires further validation
Recent studies using patient-derived dopaminergic neurons demonstrate increased sensitivity to TOP2 poisons when TDP2 is suppressed 6Topoisomerase II dysfunction in Parkinson's disease dopaminergic neurons (2024)Open reference.
Alzheimer’s Disease (AD)
In AD, TDP2 dysfunction contributes through:
-
Neuronal Loss: Progressive accumulation of unresolved TOP2cc contributes to hippocampal and cortical neuron death
-
Genomic Instability: TDP2 deficiency promotes chromosomal aberrations in vulnerable neurons
-
DNA Damage Response Activation: Chronic DNA damage signaling may contribute to neuroinflammation
-
Interaction with AD Pathology: Amyloid-β and tau pathology may impair DNA repair capacity, including TDP2 function
The accumulation of DNA damage in AD brains correlates with cognitive decline and is considered a key feature of the disease 7DNA damage response in AD (2021)Open reference.
Ataxia
Biallelic TDP2 mutations cause a hereditary ataxia syndrome characterized by:
-
Early-onset cerebellar ataxia
-
Oculomotor apraxia
-
Peripheral neuropathy
-
Progressive motor dysfunction
The disease mechanism involves complete loss of TDP2 function, leading to catastrophic accumulation of TOP2cc during normal neural development 8DNA topoisomerase II in aging and neurodegeneration (2022)Open reference.
Interaction Network
Protein-Protein Interactions
TDP2 interacts with numerous cellular proteins:
| Partner | Interaction Type | Function |
|---|---|---|
| p53 | Direct binding | Transcriptional activation of DNA repair genes |
| NF-κB | Direct binding | Modulates inflammatory responses |
| XRCC1 | Complex formation | Coordinates DSB repair |
| DNA-PKcs | Substrate | Involved in NHEJ pathway |
| PARP1 | Activation | DNA damage signaling |
| TDP1 | Cooperativity | Parallel TOP1/TOP2 repair |
Pathway Participation
TDP2 participates in several key cellular pathways:
-
DNA damage response (DDR) signaling
-
Non-homologous end joining (NHEJ)
-
Base excision repair (BER)
-
Transcription regulation
-
Apoptotic signaling
Therapeutic Implications
Small Molecule Inhibitors
TDP2 inhibitors are being developed as:
-
Chemotherapy adjuvants: Sensitize cancer cells to TOP2 poisons
-
Research tools: Understand TDP2 function in various contexts
Therapeutic Activation
Strategies to enhance TDP2 activity:
-
Gene therapy: Viral vector delivery of TDP2
-
Small molecule activators: Compounds that enhance TDP2 expression or activity
-
Reduction of TOP2cc: Antioxidants to reduce oxidative TOP2 stabilization
Neuroprotective Approaches
Potential neuroprotective strategies include:
-
DNA repair enhancement: Upregulating TDP2 and related repair proteins
-
TOP2cc prevention: Using antioxidants to reduce oxidative TOP2 stabilization
-
Cellular resilience: Enhancing DNA damage tolerance mechanisms
Research Directions
Unresolved Questions
-
Neuronal Specificity: Why are neurons particularly dependent on TDP2?
-
Regulation: How is TDP2 activity regulated in response to cellular stress?
-
Cross-talk: What is the relationship between TDP2 and other DNA repair pathways in neurons?
-
Therapeutic Target: Can TDP2 modulation provide therapeutic benefit in neurodegenerative diseases?
Ongoing Studies
Current research focuses on:
-
Developing TDP2-targeted therapies for neuroprotection
-
Understanding the interplay between TDP2 and mitochondrial function
-
Identifying biomarkers for DNA repair deficiency in neurodegeneration
-
Exploring the role of TDP2 in aging-related neuronal decline
Cross-References
See Also
References
- TDP2 and DNA repair in neurons (2020)
- TDP2 function and neurological disease (2020)
- Tyrosyl-DNA phosphodiesterases in neurodegeneration (2019)
- TDP2 polymorphisms and susceptibility to neurodegenerative diseases (2023)
- Topoisomerase inhibitors for neurodegeneration (2021)
- Topoisomerase II dysfunction in Parkinson's disease dopaminergic neurons (2024)
- DNA damage response in AD (2021)
- DNA topoisomerase II in aging and neurodegeneration (2022)
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.